$WGS

GeneDx Holdings Corp.

Nasdaq · Healthcare · Services-Health Services · Stamford, CT

WGS chart

What traders are saying about $WGS

Latest posts

GeneDx Holdings Corp. news

GeneDx Holdings Corp. key financials

USD2025202420232022
Revenue$427.5M$305.4M$202.6M$234.7M
Net income-$21.0M-$52.3M-$175.8M-$549.0M
Diluted EPS$-0.73$-1.94$-7.23$-53.63
Total assets (year end)$523.7M$419.4M$418.8M$490.9M
Cash and equivalents (year end)$105.0M$85.2M$99.7M$123.9M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About GeneDx Holdings Corp.

Ticker
WGS (Nasdaq)
Industry
Services-Health Services
Headquarters
Stamford, CT
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1818331
Former names
Sema4 Holdings Corp., CM Life Sciences, Inc.

Frequently asked questions

What exchange is GeneDx Holdings Corp. listed on?

GeneDx Holdings Corp. trades on the Nasdaq under the ticker symbol WGS.

What industry is GeneDx Holdings Corp. in?

GeneDx Holdings Corp. is classified by the SEC under "Services-Health Services", part of the Healthcare sector on StockTweeting.

Where is GeneDx Holdings Corp. headquartered?

GeneDx Holdings Corp.'s business address on file with the SEC is in Stamford, CT.

When does GeneDx Holdings Corp.'s fiscal year end?

GeneDx Holdings Corp.'s fiscal year ends on December 31.

How much revenue did GeneDx Holdings Corp. report?

GeneDx Holdings Corp. reported $427.5M in revenue for calendar year 2025, according to its SEC filings.